NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER

被引：0
|
作者：
Yoon, G. [1 ]
Ralevski, E. [1 ]
Arias, A. J. [1 ]
Limoncelli, D. [1 ]
Newcomb, J. [1 ]
Levy, L. [1 ]
Jane, J. S. [1 ]
Krystal, J. H. [1 ]
Petrakis, I. L. [1 ]
机构：
[1] Yale Univ, Dept Psychiat, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2018年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
869
引用
收藏
页码：236A / 236A
页数：1
相关论文
共 50 条
  • [41] Alcohol Use Disorder and Depressive Disorders
    McHugh, R. Kathryn
    Weiss, Roger D.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2019, 40 (01): : 3 - 10
  • [42] Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy
    Goforth, Harold W.
    Holsinger, Tracey
    JOURNAL OF ECT, 2007, 23 (01) : 23 - 25
  • [43] Duloxetine - A review of its use in the treatment of major depressive disorder
    Frampton, James E.
    Plosker, Greg L.
    CNS DRUGS, 2007, 21 (07) : 581 - 609
  • [44] DuloxetineA Review of its Use in the Treatment of Major Depressive Disorder
    James E. Frampton
    Greg L. Plosker
    CNS Drugs, 2007, 21 : 581 - 609
  • [45] Driving Under the Influence of Alcohol in People With Major Depressive Episodes and Alcohol Use Disorder
    Park, Ji-Yeun
    Peterson, Brent M.
    Kim, Jinsil
    Galbadage, Thushara
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (01): : 54 - 63
  • [46] Therapeutic potential of ketamine for alcohol use disorder
    Worrell, Stephen D.
    Gould, Thomas J.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 126 : 573 - 589
  • [47] Epigenetic predictors of naltrexone response in alcohol use disorder
    Schacht, J. P.
    Hoffman, M.
    Chen, B. H.
    Anton, R. F.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 108 - 109
  • [48] Modulation of the functional connectome in major depressive disorder by ketamine therapy
    Sahib, Ashish K.
    Loureiro, Joana R.
    Vasavada, Megha
    Anderson, Cole
    Kubicki, Antoni
    Wade, Benjamin
    Joshi, Shantanu H.
    Woods, Roger P.
    Congdon, Eliza
    Espinoza, Randall
    Narr, Katherine L.
    PSYCHOLOGICAL MEDICINE, 2022, 52 (13) : 2596 - 2605
  • [49] A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
    Lapidus, Kyle A. B.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Soleimani, Laili
    Feder, Adriana
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    BIOLOGICAL PSYCHIATRY, 2014, 76 (12) : 970 - 976
  • [50] Efficacy of different doses of ketamine as a bolus in major depressive disorder
    Kheirkhah, Farzan
    Tayyebi, Gooya
    Rabiee, Seyed Mozaffar
    Moghadamnia, Ali-Akbar
    Bijani, Ali
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2018, 9 (03) : 220 - 227
12345